Ferdinandos Skoulidis, M.D., Ph.D., MRCP
Department of Thoracic-Head & Neck Med Onc, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2011 | University of Cambridge, Cambridge, GBR, PHD, Oncology |
| 2000 | Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, GRC, MD, Medicine |
Postgraduate Training
| 2014-2015 | Instructor (Advanced Scholar), University of Texas MD Anderson Cancer Center, Houston, TX |
| 2013-2014 | Clinical Fellowship, Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2005-2005 | Research Fellowship, GI Oncology/Lymphoma, Royal Marsden Hospital, Sutton |
| 2002-2004 | Senior House Officer (Clinical Residency), Addenbrooke's SHO General Medical Rotation, Addenbrooke's Hospital, Cambridge |
Experience & Service
Academic Appointments
Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021
Selected Publications
Peer-Reviewed Articles
- Mak MP, Tong P, Diao L, Cardnell RJ, Gibbons DL, William WN, Skoulidis F Parra ER, Rodriguez-Canales J, Wistuba II, Heymach JV, Weinstein JN, Coombes KR, Wang J, Byers LA. A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial to mesenchymal transition. Clin Cancer Res 22(3):609-20, 2016. e-Pub 2015. PMID: 26420858.
- Skoulidis F, Byers LA, Diao L, Papadimitrakopoulou VA, Tong P, Izzo J, Behrens C, Kadara H, Parra ER, Canales JR, Zhang J, Giri U, Gudikote J, Cortez MA, Yang C, Fan Y, Peyton M, Girard L, Coombes KR, Toniatti C, Heffernan TP, Choi M, Frampton GM, Miller V, Weinstein JN, Herbst RS, Wong KK, Zhang J, Sharma P, Mills GB, Hong WK, Minna JD, Allison JP, Futreal A, Wang J, Wistuba II, Heymach JV. Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities. Cancer Discov 5(8):860-77, 2015. e-Pub 2015. PMID: 26069186.
- Chandra A, Grecco HE, Pisupati V, Perera D, Cassidy L, Skoulidis F, Ismail SA, Hedberg C, Hanzal-Bayer M, Venkitaraman AR, Wittinghofer A, Bastiaens PI. The GDI-like solubilizing factor PDEδ sustains the spatial organization and signalling of Ras family proteins. Nat Cell Biol 14(2):148-158, 2012. e-Pub 2011. PMID: 22179043.
- Hattori H, Skoulidis F, Russell P, Venkitaraman AR. Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressor. Mol Cancer Ther 10(4):670-678, 2011. e-Pub 2011. PMID: 21289082.
- Skoulidis F, Cassidy LD, Pisupati V, Jonasson JG, Bjarnason H, Eyfjord JE, Karreth FA, Lim M, Barber LM, Clatworthy SA, Davies SE, Olive KP, Tuveson DA, Venkitaraman AR. Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer. Cancer Cell 18(5):499-509, 2010. e-Pub 2010. PMID: 21056012.
- Kiani-Alikhan S, Skoulidis F, Barroso A, Nuovo G, Ushiro-Lumb I, Breuer J, Lister A, Mattes F. Enterovirus infection of neuronal cells post-Rituximab. Br J Haematol 146(3):333-335, 2009. e-Pub 2009. PMID: 19466969.
- Formica V, Massara MC, Portarena I, Fiaschetti V, Grenga I, Del Vecchio Blanco G, Sileri P, Tosetto L, Skoulidis F, Pallone F, Roselli M. Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients. Cancer Biomark 5(4):167-175, 2009. PMID: 19729826.
- Skoulidis F, Alexander GJ, Davies SE. Ma huang associated acute liver failure requiring liver transplantation. Eur J Gastroenterol Hepatol 17(5):581-584, 2005. PMID: 15827451.
- Skoulidis F, Morgan MS, MacLeod KM. Penicillium marneffei: a pathogen on our doorstep?. J R Soc Med 97(8):394-396, 2004. PMID: 15286196.
Invited Articles
- Skoulidis F, Cunningham D. Monoclonal antibodies cetuximab and bevacizumab in combination with irinotecan in colorectal cancer therapy: comments on regulatory approved indications. Advances in Colorectal Cancer, 2005.
Book Chapters
- Skoulidis F, Eisen T. Targeted therapies for metastatic conventional – type renal cell carcinoma. In: Renal Cell Carcinoma (Oxford American Oncology Library). OUP: USA, 2014.
- Skoulidis F, Chua YJ, Cunningham D. Squamous cancer of the esophagus. In: Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach. Blackwell Publishing Ltd, 114-145, 2009.
Grant & Contract Support
| Title: | Impact of NLRC5 loss on the biology, immune contexture and response of KRAS-mutant lung adenocarcinoma (LUAC) to immunotherapy |
| Funding Source: | Andrew Sabin Family Foundation Fellowship |
| Role: | Principal Investigator |
Patient Reviews
CV information above last modified December 05, 2023